AbbVie (ABBV) Strengthens Pays $700M to Strengthen Oncology Portfolio with ISB 2001
AbbVie Inc. (NYSE:ABBV) is one of Goldman Sachs’ top healthcare stock picks.
Posts Tagged ‘NYSE:ABBV’
Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
The healthcare sector has been under pressure, underperforming the S&P 500 over the past several years.
AbbVie (ABBV) Updates 2025 EPS Guidance with $823M IPR&D Expense
AbbVie Inc. (NYSE:ABBV) is one of the 7 most undervalued pot stocks to buy according to analysts.
7 Most Undervalued Pot Stocks To Buy According To Analysts
The global cannabis market was worth $26.86 billion in 2022, Spherical Insights & Consulting data shows.
AbbVie Inc. (ABBV): A Bull Case Theory
We came across a bullish thesis on AbbVie Inc. on Dividend Talks’s Substack. In this article, we will summarize the bulls’ thesis on ABBV.
Morgan Stanley Maintained an Overweight Rating on AbbVie (ABBV)
AbbVie Inc. (NYSE:ABBV) is one of the best high growth stocks.
10 High Growth Dividend Paying Stocks to Buy
In 2024, macroeconomic uncertainty, election year volatility, and weakened consumer confidence led many corporations to adopt a more cautious approach, resulting in subdued dividend...
AbbVie to Acquire Capstan Therapeutics for $2.1B, Boosting Autoimmune Pipeline
AbbVie Inc. (NYSE:ABBV) is one of the most undervalued large cap stocks to buy according to analysts.
13 Most Undervalued Large Cap Stocks to Buy According to Analysts
On July 3, Ben Preston, Portfolio Manager at Orbis Investments, appeared on CNBC to suggest that investors look past the constant political headlines and market volatility and...
AbbVie’s Elahere Market Expected to Skyrocket to $6B by 2034 in Ovarian Cancer Treatment
AbbVie Inc. (NYSE:ABBV) is one of the undervalued S&P 500 stocks to buy according to hedge funds.
10 Undervalued S&P 500 Stocks to Buy According to Hedge Funds
On June 24, Paul Hickey, Bespoke Investment Group co-founder, joined 'Squawk Box' on CNBC to suggest that periods of widespread fear often present good buying opportunities.
AbbVie (ABBV) Reports Positive Migraine Drug Results in Phase 3 Trial
AbbVie Inc. (NYSE:ABBV) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing.
Is AbbVie the Best Dividend Stock in Big Pharma Today?
The company holds the title of a Dividend King, having raised its dividend for 52 straight years.
10 Undervalued Blue Chip Stocks Analysts Recommend for Smart Investing
Blue-chip stocks are great assets for investors looking for opportunities to grow their capital in the long term. Some call them steady oaks in the forest of finance.
AbbVie (ABBV) Pipeline Bolstered as FDA Approves Mavyret Label Expansion for Hepatitis C
AbbVie Inc. (NYSE:ABBV) is one of the 12 best healthcare stocks to buy now.
AbbVie, ADARx Pharmaceuticals Partner to Develop Next-Gen siRNA Therapeutics
AbbVie Inc. (NYSE:ABBV) is one of the best stocks to buy for beginners now.
12 Best Healthcare Stocks to Buy Now
Healthcare companies in the US are facing policy headwinds under President Donald Trump's Administration.
10 Best Stocks to Buy For Beginners Now
On June 12, Dan Niles, Niles Investment Management founder and portfolio manager, joined CNBC's 'Squawk Box' to discuss the state of the economy and how he expects the market ...
AbbVie Secures FDA Approval to Expand Mavyret’s Label
The company announced that the US FDA has expanded the approved use of its oral antiviral drug Mavyret, developed in partnership with Enanta Pharmaceuticals, Inc.
Dividend Stock Portfolio For Retirement
As retirement nears, maintaining financial security becomes a top priority for investors.
Key Drivers Behind AbbVie’s (ABBV) Performance
RS Investments, an investment management company, released its “RS Large Cap Value Strategy” first quarter 2025 investor letter.
AbbVie (ABBV) has a Stable and Highly Profitable Business Model
Renaissance Investment Management, an investment management company, released its Q1 2025 “Large Cap Growth Strategy” investor letter.
AbbVie (ABBV) Soared on Favorable Tailwinds
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” first quarter 2025 investor letter.
Jim Cramer On AbbVie: Makes “Sense To Start a Position in the Stock”
“Or how about one of my absolute favorites right here too, AbbVie. Now here's a drug company with no patent cliff in sight whatsoever.
Jim Cramer Commented on 7 Hard-to-Own Safety Stocks
“When interest rates go up, even if they go up just a little, you can see lots of very good well-known stocks with juicy dividends just get pummeled.
20 Best Dividend Growth Stocks with High Yields
Dividend-paying stocks have been gaining popularity among investors due to their long-term advantages.
Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
10 Best Income Stocks to Invest in Now
Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy.
AbbVie Inc. (ABBV): A Bull Case Theory
We came across a bullish thesis on AbbVie Inc. (ABBV) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc.
ChatGPT Stock Advice: Top 12 Stock Recommendations
This article looks at ChatGPT Stock Advice: Top 12 Stock Recommendations.
Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential
The healthcare industry, an essential component of global well-being and economic resilience, is undergoing significant changes.
AbbVie Inc. (NYSE:ABBV) Q1 2025 Earnings Call Transcript
Operator: Welcome to the AbbVie First Quarter 2025 Earnings Conference Call. All participants will be able to listen only until the question and answer portion of this call.
15 Best Dividend Stocks to Buy for Long-Term Passive Income
Passive income, which refers to money earned with little ongoing effort, was once largely the domain of the wealthy – those who could afford to invest in rental properties or...
30 Growing Dividend Stocks with Low PE Ratios
Value stocks are enjoying a rare period of strength amid this year’s broader market downturn.
10 Best Stocks That Will Always Grow
Threats of an impending recession are looming over the stock market due to Trump's tariffs and macroeconomic uncertainty.
Jim Cramer’s Game Plan for Next Week: 25 Stocks in Focus
On Thursday, Jim Cramer, the host of Mad Money, walked viewers through what he described as an important week ahead for Wall Street, with earnings season hitting full stride and...
15 Best Large-Cap Value Stocks to Buy as the Recession Hits
Goldman Sachs highlighted that equities around the world traded in and out of a bear market — which is often defined as a 20% decline from the recent peak.
10 Innovative Healthcare Stocks to Watch in 2025
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.
10 Best Dividend Monarchs to Invest in Now
Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware of a lesser-known group called Dividend...
10 Best Pharma Stocks to Buy for Long Term Growth
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.
10 High Growth Forever Dividend Stocks To Invest In
Dividend stocks have trailed the broader market over the past two years, largely due to investors favoring AI-focused companies.
Here’s Why Clearbridge Growth Strategy Sold AbbVie (ABBV)
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” first quarter 2025 investor letter.
Long-Term Stock Portfolio: 15 Best Stocks for 15 Years
Russell Investments believes that 3 features are defining the market outlook for 2025.
15 Best Dividend Aristocrat Stocks with Over 3% Yield
Dividend Aristocrats are the companies that have raised their payouts for 25 consecutive years or more.
13 Best Healthcare Dividend Stocks to Invest in
The US healthcare sector has been at the forefront since the emergence of COVID-19 in 2020, leading to a significant transformation in the industry.
11 Best Pharma Stocks to Buy According to Hedge Funds
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
10 Magnificent Dividend Growth Stocks to Invest In
Dividend stocks remain a popular choice among investors due to their ability to generate steady income.
